Clear Street Markets LLC Vertex Pharmaceuticals Inc Transaction History

Clear Street Markets LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$392.81 - $485.53 $13,355 - $16,508	34 New	34 $16,000
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $2,744 - $3,285	-8 Reduced 27.59%	21 $9,000
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $19,952 - $21,385	-59 Reduced 67.05%	29 $10,000
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $27,668 - $30,968	88 New	88 $31,000
Q3 2022 Nov 02, 2022	BUY	$273.83 - $305.53 $276,020 - $307,974	1,008 New	1,008 $292,000
Q2 2022 Aug 02, 2022	SELL	$234.96 - $292.55 $270,438 - $336,725	-1,151 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$221.42 - $260.97 $254,854 - $300,376	1,151 New	1,151 $300,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Street Markets LLC with notifications on news.